Product
Z650
1 clinical trial
1 indication
Indication
Esophageal squamous cell carcinomaClinical trial
A Phase Ib, Multi-center, Open-label Study of Z650 in Advanced Esophageal Squamous Cell Carcinoma (ECSS) With Epidermal Growth Factor Receptor (EGFR) Over Expression or Gene AmplificationStatus: Completed, Estimated PCD: 2022-12-13